A biopharmaceutical company focused on the discovery, development and commercialization of new small molecule drugs for the treatment of cardiovascular diseases.
The best Bull and Bear pitches based on recency and number of recommendations.
europe approvals and nice royalty situation, still are'nt being valued.
CV Therapeutics is a development-stage company specializing in small-molecule drugs to treat chronic cardiovascular diseases. The firm's only marketed product Ranexa, licensed from a Roche subsidiary, treats chronic angina for select patients by… More
Read the most recent pitches from players about CVTX.DL.
Find the members with the highest scoring picks in CVTX.DL.
See what the Wall Street professionals think, according to their public statements and filings.